3Spiess P, Yang J C, Rosenberg S A. In vivo antitumor activity of tumor infiltratinglymphocytes expanded in recombinant interleukin-2 [J]. J Natl Cancer Inst, 1987, 79(5) :1067-1075.
4Rosenberg S A, Spiess P, Lafreniere R. A new approach to the adoptive immunotherapy of cancer with tumor infiltrating lymphocytes[J]. Science,1986, 233(4770):1318-1321.
5Rosenberg S A, Pachard B S, Aebersold P M, et al. Use of tumor infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma[J]. N Engl J Med, 1988, 319 (25):1676-1680.
6Aoki Y, Takakuwa K, Kodama S, et al. Use of adoptive transfer of tumor-infiltrating lymphocytes alone or in combination with cisplatin-containing chemotherapy in patients with epithelial ovarian cancer[J]. Cancer Res, 1991, 51(7):1934-1939.
7Rabinowich H, Cohen R, Brudermian I, et al. Functional analysis of mononuclear cells infiltrating into tumors:Lysis of autologous humantumor cells by cultured infiltrating lymphocytes [J]. Cancer Res, 1987, 47(1):173-177.
8Margolin KA, Negrin RS, Wong KK, et al. Cellular immunotherapy and autologous transplantation for hematologic malignancy.Immunol Rev, 1997,157: 231-240.
9Hoffman DM, Gitlitz BJ, Belldegrun A, et al. Adoptive cellular therapy. Senim Oncol, 2000,27 : 221-233.
10Schmidt-Wolf IG, Lefterova P , Mebta BA , et al . Phenotypic characterization and identification of effect or cells involved in tumor cell recognition of cytokine-induced killer cells. Exp Hematol , 1993,21:1673-1679.
